Eagle Pharmaceuticals shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Eagle Pharmaceuticals by GSA Capital Partners
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $435k | 83k | 5.23 |
2023-09-30 | $401k | 25k | 15.76 |
2023-06-30 | $711k | 37k | 19.44 |
2023-03-31 | $404k | 14k | 28.40 |
2022-09-30 | $611k | 23k | 26.41 |
2022-06-30 | $758k | 17k | 44.44 |
2022-03-31 | $813k | 16k | 49.51 |
2021-12-31 | $243k | 4.8k | 51.02 |
2020-03-31 | $283k | 6.1k | 46.08 |
2019-12-31 | $623k | 10k | 60.09 |
2019-09-30 | $670k | 12k | 56.58 |
2019-06-30 | $1.1M | 19k | 55.67 |
2019-03-31 | $1.2M | 23k | 50.49 |
2018-12-31 | $1.3M | 32k | 40.28 |
2018-09-30 | $1.7M | 24k | 69.33 |
2018-06-30 | $401k | 5.3k | 75.66 |
2018-03-31 | $411k | 7.8k | 52.69 |
2017-12-31 | $2.1M | 40k | 53.42 |
2017-09-30 | $948k | 16k | 59.62 |
2017-06-30 | $2.2M | 29k | 78.88 |
2017-03-31 | $2.7M | 32k | 82.94 |
2016-03-31 | $1.3M | 32k | 40.50 |
2015-12-31 | $688k | 7.8k | 88.69 |
2015-09-30 | $751k | 10k | 74.03 |
2015-03-31 | $901k | 22k | 41.91 |